[Aspects of psychopharmacological treatment of personality disorders].
D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications; D002220:Carbamazepine / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D002749:Chlorprothixene / Q000627:therapeutic use; D003704:Dementia / Q000188:drug therapy*; D004660:Encephalitis / Q000150:complications; D004827:Epilepsy / Q000150:complications* / Q000188:drug therapy; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008581:Meningitis / Q000150:complications; D001523:Mental Disorders / Q000188:drug therapy; D008728:Methotrimeprazine / Q000627:therapeutic use; D010554:Personality Disorders / Q000188:drug therapy* / Q000209:etiology; D010640:Phenothiazines / Q000627:therapeutic use; D011346:Prochlorperazine / Q000627:therapeutic use; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014272:Trifluperidol / Q000627:therapeutic use
D000927:Anticonvulsants; D000928:Antidepressive Agents; D010640:Phenothiazines; D014149:Tranquilizing Agents; D002220:Carbamazepine; D008728:Methotrimeprazine; D002749:Chlorprothixene; D013881:Thioridazine; D014272:Trifluperidol; D005476:Fluphenazine; D002746:Chlorpromazine; D011346:Prochlorperazine
Aspecte ale tratamentului psihofarmacologic al tulburărilor de personalitate.